Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings
Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.
By CNBC ยท CNBC
Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.